Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02076113 · ClinicalTrials.gov registry record · NA
Cervical Spondylotic Myelopathy Surgical Trial
A NA study of Cervical Spondylosis With Myelopathy, sponsored by Lahey Clinic.
- Active
- Registry status
- NA
- Development phase
- 269
- Enrollment target
- 16
- Study locations
NCT02076113: Active NA study of Cervical Spondylosis With Myelopathy, sponsored by Lahey Clinic.
NCT02076113 is a NA study of Cervical Spondylosis With Myelopathy that is active but no longer recruiting, run by Lahey Clinic. The registered enrollment target is 269 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). The trial reports 16 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02076113, a NA study of Cervical Spondylosis With Myelopathy, is active but no longer recruiting, sponsored by Lahey Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 269 participants
- Enrollment target
- 16
- Study locations
Study Summary
The purpose of the study is to determine the optimal surgical approach (ventral vs dorsal) for patients with multi-level cervical spondylotic myelopathy (CSM). There are no established guidelines for the management of patients with CSM, which represents the most common cause of spinal cord injury and dysfunction in the US and in the world. This study aims to test the hypothesis that ventral surgery is associated with superior Short Form-36 physical component Score (SF-36 PCS) outcome at one year follow-up compared to dorsal approaches and that both ventral and dorsal surgery improve symptoms of spinal cord dysfunction measured using the modified Japanese Orthopedic Association Score (mJOA). A secondary hypothesis is that health resource utilization for ventral surgery, dorsal fusion, and laminoplasty surgery are different. A third hypothesis is that cervical sagittal balance post-operatively is a significant predictor of SF-36 PCS outcome.
Primary Outcome
Standardized measure of patient's functional health and well being as reported by the patient. The SF-36 physical component summary (PCS) scores range from 0 to 100, with higher scores representing better quality of life.
Conditions Studied
Interventions
- PROCEDURE Ventral (Front) decompression with Fusion
- PROCEDURE Dorsal (Back) Decompression with Fusion
- PROCEDURE Dorsal (back) Laminoplasty
Study Locations (16)
New York
- Hospital for Special Surgery - New York
- Columbia - New York
Ohio
- Cleveland Clinic Foundation - Cleveland
- MetroHealth - Cleveland
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Wisconsin
- University of Wisconsin - Madison
- Medical College of Wisconsin - Milwaukee
California
- University of California- San Francisco - San Francisco
Georgia
- Emory - Atlanta
Kansas
- University of Kansas Medical Center - Kansas City
Massachusetts
- Lahey Hospital and Medical Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2014-04-01 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What the registry record for NCT02076113 still lists
NCT02076113 is an interventional study that assigns participants to a tested intervention. The registered 269 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Cervical Spondylosis With Myelopathy appearing as the primary indexed condition, and to 3 interventions - of which Ventral (Front) decompression with Fusion is the first listed.
NCT02076113 lists 16 locations in 12 states (New York, Ohio, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT02076113 about?
NCT02076113 is a clinical study titled "Cervical Spondylotic Myelopathy Surgical Trial". The purpose of the study is to determine the optimal surgical approach (ventral vs dorsal) for patients with multi-level cervical spondylotic myelopathy (CSM). There are no established guidelines for the management of patients with CSM, which represents the most common cause of spinal cord injury an...
What is the current status of trial NCT02076113?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 269 participants. The study started on 2014-04-01. Estimated completion is 2026-12-30.
What conditions does trial NCT02076113 study?
This clinical trial studies the following conditions: Cervical Spondylosis With Myelopathy.
What interventions are being tested in trial NCT02076113?
The interventions under investigation include: Ventral (Front) decompression with Fusion (PROCEDURE), Dorsal (Back) Decompression with Fusion (PROCEDURE), Dorsal (back) Laminoplasty (PROCEDURE).
Who is sponsoring clinical trial NCT02076113?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02076113 being conducted?
This trial has 16 study locations across California, Georgia, Kansas, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Spondylosis With Myelopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02076113's enrollment target sits among peer trials
269 392nd of 2000 higher than 1,609 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04802291 · 269 participants · NA
HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity
- NCT06500455 · 269 participants · Phase 3
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
- NCT06630676 · 269 participants · NA
The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI